Bottom line
VGHCX vs IXJ: the short answer
VGHCX (Vanguard Health Care Fund) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 55% by weight.
VGHCX is cheaper at 0.33% vs 0.38% — a difference of $5.00 a year per $10,000 invested.
Over five years, VGHCX returned +6.6% a year vs +6.4% for IXJ.
Updated Nov 19, 2026
VGHCX vs IXJ side by side
| VGHCX | IXJ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Vanguard | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.33% | 0.38% |
| Annual cost per $10k | $33 | $38 |
| 10-yr cost on $10k (prospectus) | $418 | $480 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +17.3% | +14.9% |
| 5-yr return (annualized) | +6.6% | +6.4% |
| 10-yr return (annualized) | +7.7% | +8.2% |
| Best quarter | +16.8% | +13.6% |
| Worst quarter | −12.3% | −11.8% |
| Net assets (fund) | $38.2B | $3.8B |
| Number of holdings | 97 | 124 |
| Portfolio turnover | 47% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VGHCX | IXJ | Difference |
|---|---|---|---|
| 2025 | +17.3% | +14.9% | +2.4% |
| 2024 | −1.6% | +0.6% | −2.2% |
| 2023 | +5.4% | +3.5% | +1.9% |
| 2022 | −1.1% | −4.7% | +3.6% |
| 2021 | +14.3% | +19.5% | −5.2% |
| 2020 | +12.6% | +12.5% | +0.1% |
| 2019 | +22.9% | +23.4% | −0.4% |
| 2018 | +1.2% | +2.9% | −1.7% |
Source: Fund prospectus bar charts
Holdings overlap
13 of VGHCX's top 25 holdings also appear in IXJ's top 25.
| Holding | VGHCX | IXJ |
|---|---|---|
| Eli Lilly & Co | 8.61% | 10.93% |
| Merck & Co Inc | 5.44% | 4.12% |
| Johnson & Johnson | 4.83% | 7.04% |
| AstraZeneca PLC | 4.59% | 3.76% |
| UnitedHealth Group Inc | 4.05% | 4.40% |
| Gsk Plc | 3.00% | 1.38% |
| Intuitive Surgical Inc | 2.52% | 1.83% |
| CVS Health Corp | 2.52% | 1.71% |
| Vertex Pharmaceuticals Inc | 2.36% | 1.64% |
| AbbVie Inc | 2.30% | 5.12% |
| Danaher Corp | 2.18% | 1.56% |
| Elevance Health Inc | 1.83% | 1.09% |
| Roche Holding AG | 1.18% | 3.75% |
Source: SEC Form N-PORT
VGHCX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between VGHCX and IXJ?
Which is cheaper, VGHCX or IXJ?
Should I own both VGHCX and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.